Media & Resources

As the AIDS vaccine field moves toward larger-scale efficacy trials, investigators’ findings could reshape enrollment in developing nations.

New class of viral vector tapped to target primary site of HIV replication; Agreement marks IAVI’s first product development partnership with Japanese company.

On August 8, South African President Thabo Mbeki dismissed his Deputy Health Minister, Nozizwe Madlala-Routledge, a well-respected figure in the international HIV/AIDS world. In a letter to Madlala-Routledge explaining his decision, Mbeki complained that the deputy minister had traveled to Madrid in June on official business without his approval.  She traveled to Madrid, to attend…

Forms Partnership with State University of New York Downstate Medical Center.

New Initiative Builds on the Work of Global Political Advocacy Initiative.

The International AIDS Vaccine Initiative (IAVI) and the Spanish AIDS NGO grupo de Trabajo sobre tratamientos del VIH (gTt) are grateful to the Spanish government for their one-year contribution of one million Euro to IAVI for the development of an AIDS vaccine. Leire Pajin, the Secretary of State for International Cooperation, made the announcement about…

The International AIDS Vaccine Initiative (IAVI) commends the leaders attending the Group of Eight (G8) Summit in Heiligendamm, Germany for prioritizing the development needs of Africa and policies to support forward-looking innovation policies that can help translate novel research concepts into tangible health products and services.

New York, May 14, 2007— On May 18, 1997, during a commencement speech at Morgan State University, President Bill Clinton challenged the world to develop an AIDS vaccine within a decade, setting a “new national goal for science in the age of biology.” Ten years after Clinton’s speech, an effective AIDS vaccine continues to elude…